NCT06723015 - Tau PET Outcomes With Anti-amyloid Immunotherapies | Biotech Hunter

Enrollment

135

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

August 31, 2028

Study Completion Date

August 31, 2028

Conditions

Cognitive Impairment, MildDementia, MildAlzheimer Disease

Interventions

DRUG

18F-AV-1451

"Subjects will receive two Tau PET (18F--AV-1451) brain scans with approximately 10 mCi (370 MBq) (+/- 10%mCi) of 18F-AV-1451. Images will be collected for a 20-minute acquisition between 80-100 minutes after injection.~Tau PET scans will occur at baseline and 12-18 months after completing anti-amyloid immunotherapy treatment.."

Trial Locations (1)

55905

Mayo Clinic, Rochester